Katrin Aslan
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.
Journal: Nature medicine
Published: August 05, 2024
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors.
Journal: Journal for immunotherapy of cancer
Published: June 21, 2024
T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cells.
Journal: Neuro-oncology advances
Published: October 05, 2022
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.
Journal: Cancer immunology research
Published: September 01, 2022
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 14, 2021
Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes.
Journal: Neuro-oncology advances
Published: November 05, 2021
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas.
Journal: Nature cancer
Published: July 15, 2020
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.
Journal: Nature communications
Published: November 25, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026